Ebola medical therapy: Difference between revisions
(Created page with "{{Ebola}} {{CMG}} ==Overview== frame|right|A hospital isolation ward in [[Gulu, Uganda during the October 2000 out...") |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Ebola}} | {{Ebola}} | ||
Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | |||
{{CMG}} | {{CMG}} | ||
==Medical Therapy== | |||
== | |||
[[Image:Ebola outbreak in Gulu Municipal Hospital.jpg|frame|right|A hospital isolation ward in [[Gulu]], [[Uganda]] during the October 2000 outbreak]] | [[Image:Ebola outbreak in Gulu Municipal Hospital.jpg|frame|right|A hospital isolation ward in [[Gulu]], [[Uganda]] during the October 2000 outbreak]] | ||
Treatment is primarily supportive and includes: | Treatment is primarily supportive and includes: | ||
| Line 14: | Line 17: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Ebola| ]] | |||
[[Category:Mononegavirales]] | |||
[[Category:Viral diseases]] | |||
[[Category:Biological weapons]] | |||
[[Category:Zoonoses]] | |||
[[Category:Hemorrhagic fevers]] | |||
[[Category:Needs overview]] | |||
[[Category:Needs content]] | |||
{{WH}} | |||
{{WS}} | |||
Revision as of 18:34, 14 December 2012
|
Ebola Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Postmortem Care |
|
Case Studies |
|
Ebola medical therapy On the Web |
|
American Roentgen Ray Society Images of Ebola medical therapy |
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Medical Therapy
Treatment is primarily supportive and includes:
- Minimizing invasive procedures
- Balancing electrolytes since patients are frequently dehydrated
- Replacing lost coagulation factors to help stop bleeding
- Maintaining oxygen and blood levels
- Treating any complicating infections.
Convalescent Plasma (factors from those who have survived Ebola infection) shows promise as a treatment for the disease. Ribavirin is ineffective. Interferon is also thought to be ineffective. In monkeys, administration of an inhibitor of coagulation (rNAPc2) has shown some benefit, protecting 33% of infected animals from a usually 100% (for monkeys) lethal infection (unfortunately this inoculation does not work on humans). In early 2006, scientists at USAMRIID announced a 75% recovery rate after infecting four rhesus monkeys with Ebola virus and administering antisense drugs.[1]
References
- ↑ "USAMRIID press release" (PDF) (Press release).